A government advisory panel’s recommendation to alter decades-long policy on routine hepatitis B vaccination for newborns has sparked immediate concern among public health officials. The panel, recently appointed by Health and Human Services Secretary Robert F. Kennedy jr., suggested scaling back universal vaccination, a move experts fear could jeopardize progress made in preventing the potentially fatal liver disease. The proposed changes signal a possible shift in federal preventative healthcare strategy and are drawing criticism over the committee’s expertise and potential influence of misinformation.
A U.S. advisory committee’s shift away from universal hepatitis B vaccination for newborns is raising concerns among public health experts, who fear the move could erode vaccination rates and increase the risk of infection. The committee, appointed by Health and Human Services Secretary Robert F. Kennedy Jr., recently recommended against routinely vaccinating all newborns against hepatitis B, a decision that deviates from decades of established preventative policy.
The change, announced on Friday, is expected to be followed by federal authorities and could mark the end of the current nationwide prevention strategy implemented in 1991. Experts warn this could lead to a resurgence of the potentially life-threatening liver disease.
“I am very concerned [about] the message being sent,” said Dr. Nicholas Brousseau, a specialist in preventative medicine at the National Institute of Public Health of Quebec (INSPQ) and an expert in hepatitis B vaccination. “It is really important to critically examine what comes out of this committee, because it transmits messages that may be false, or contain erroneous elements.”
The concern centers on the potential for decreased public trust in vaccines. “The fear is that confidence will erode and a smaller proportion of children will be vaccinated,” Dr. Brousseau added. Hepatitis B is a viral infection of the liver that can lead to cirrhosis and liver cancer, and is often transmitted from mother to child during birth.
Jesse Papenburg, a pediatrician, infectious disease specialist, and microbiologist at McGill University Health Centre, believes the decision will “increase vaccine hesitancy in the United States.” He expressed dismay at the situation, stating, “We now have people in positions of authority selling falsehoods, misinformation,” and went so far as to call it a “scientific tragedy.”
Many members of the advisory committee have faced criticism for lacking relevant expertise or for previously disseminating inaccurate information about vaccines. This raises questions about the basis for the committee’s recommendations and the potential for biased decision-making.
The new recommendation suggests that a first dose of the hepatitis B vaccine – part of a three-dose series – should no longer be routinely given to babies whose mothers test negative for the virus. While this approach may seem targeted, experts worry it could create gaps in coverage and increase the risk of infection, particularly in vulnerable populations.
According to Dr. Papenburg, who also chairs the Quebec Immunization Committee, the U.S. program implemented in 1991 led to a “considerable drop in cases of hepatitis B in the United States.” “There was no sound reason” to question this policy, he emphasized. He predicts, “It’s clear that this will decrease vaccination coverage in the United States.”
The risk of a newborn developing a chronic hepatitis B infection is estimated to be over 90%, while the risk decreases to 25-50% for children aged 1-5 years, and less than 5% for those 5 years and older, according to the INSPQ. Early vaccination is therefore crucial in preventing long-term health complications.
In Quebec, the Quebec Immunization Program (PQI) recommends three doses of the hepatitis B vaccine, administered at 2, 4, and 18 months of age. Dr. Papenburg attributes the difference in approach to the differing healthcare systems. The U.S. system is “fragmented” and marked by “accessibility problems,” which increases the risk of infectious disease transmission.
While vaccination is not mandatory in Quebec, it is strongly recommended. “We really focus on providing parents with good information so they can make the best decision for their children,” explained Dr. Brousseau. Approximately 9 out of 10 children in the province are vaccinated against hepatitis B.
Data from the Quebec Ministry of Health and Social Services shows that 88% of one-year-old children had received all recommended doses of vaccines, including the hepatitis B vaccine, in 2021-2022.
“This is a very important vaccine,” Dr. Brousseau stressed. “There is flexibility regarding the exact timing of administration… the important thing is that all children are vaccinated against hepatitis B.” He highlighted the efficiency of Quebec’s strategy, which combines the hepatitis B vaccine with other routine childhood immunizations, such as those for diphtheria, tetanus, and pertussis, reducing the number of injections needed.
